JP2024507958A5 - - Google Patents
Info
- Publication number
- JP2024507958A5 JP2024507958A5 JP2023552072A JP2023552072A JP2024507958A5 JP 2024507958 A5 JP2024507958 A5 JP 2024507958A5 JP 2023552072 A JP2023552072 A JP 2023552072A JP 2023552072 A JP2023552072 A JP 2023552072A JP 2024507958 A5 JP2024507958 A5 JP 2024507958A5
- Authority
- JP
- Japan
- Prior art keywords
- ccl
- acid sequence
- amino acid
- domain
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021078227 | 2021-02-26 | ||
| CNPCT/CN2021/078227 | 2021-02-26 | ||
| PCT/CN2022/077964 WO2022179613A1 (en) | 2021-02-26 | 2022-02-25 | Engineered immune effector cells expressing exogenously introduced cytokines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507958A JP2024507958A (ja) | 2024-02-21 |
| JP2024507958A5 true JP2024507958A5 (https=) | 2025-02-27 |
Family
ID=83048671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023552072A Pending JP2024507958A (ja) | 2021-02-26 | 2022-02-25 | 外因的に導入されたサイトカインを発現する操作された免疫エフェクター細胞 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240316201A1 (https=) |
| EP (1) | EP4298210A4 (https=) |
| JP (1) | JP2024507958A (https=) |
| KR (1) | KR20230147619A (https=) |
| CN (1) | CN116964195A (https=) |
| WO (1) | WO2022179613A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260016890A (ko) * | 2024-07-24 | 2026-02-04 | 서울대학교산학협력단 | 안전하며 효과적인 유전자세포치료 시스템 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3017442A1 (en) * | 2016-03-17 | 2017-09-21 | Yamaguchi University | Immunocompetent cell and expression vector expressing regulatory factors of immune function |
| JP2020530280A (ja) * | 2017-07-03 | 2020-10-22 | トルク セラピューティクス， インコーポレイテッド | 免疫刺激性融合分子およびその使用 |
| EP3781176A4 (en) * | 2018-04-09 | 2022-05-25 | The Trustees of the University of Pennsylvania | METHODS AND COMPOSITIONS USING A VIRAL VECTOR FOR THE EXPRESSION OF A TRANSGENE AND AN EFFECTOR |
| US11319380B2 (en) * | 2018-06-04 | 2022-05-03 | Precigen, Inc. | MUC16 specific chimeric antigen receptors and uses thereof |
| JP7241161B2 (ja) * | 2018-08-01 | 2023-03-16 | イミュニティーバイオ、インコーポレイテッド | 細胞免疫療法の安定した遺伝子改変のための、ホーミング受容体又はサイトカインとキメラ抗原受容体とを含むクアドリシストロニックシステム |
| US10918667B2 (en) * | 2018-11-20 | 2021-02-16 | Innovative Cellular Therapeutics CO., LTD. | Modified cell expressing therapeutic agent and uses thereof |
| EP3907280A4 (en) * | 2018-12-13 | 2022-06-22 | CRAGE medical Co., Limited | ANTI-GPC3 IMMUNE EFFECTOR CELL AND USE THEREOF |
| CN113557242A (zh) * | 2019-02-01 | 2021-10-26 | 得克萨斯大学体系董事会 | 用于治疗癌症的修饰的il-12 t细胞疗法 |
| CN110818803B (zh) * | 2019-07-24 | 2023-01-03 | 浙江启新生物技术有限公司 | 分泌表达il15ra-il15融合蛋白、ccl21趋化因子的嵌合抗原受体-t细胞及应用 |
| CN110590960B (zh) * | 2019-09-26 | 2020-08-28 | 武汉波睿达生物科技有限公司 | 以cd99为靶点的嵌合抗原受体及其应用 |
| CN110684739B (zh) * | 2019-11-11 | 2022-05-27 | 深圳市体内生物医药科技有限公司 | 一种嵌合抗原受体t细胞及其应用 |
| CA3170023A1 (en) * | 2020-02-27 | 2021-09-02 | Nanjing Legend Biotech Co., Ltd. | Antibodies and chimeric antigen receptors targeting glypican-3 (gpc3) and methods of use thereof |
| CN112175998A (zh) * | 2020-10-12 | 2021-01-05 | 广东昭泰体内生物医药科技有限公司 | 一种嵌合抗原受体t细胞及其应用 |
-
2022
- 2022-02-25 KR KR1020237027889A patent/KR20230147619A/ko active Pending
- 2022-02-25 US US18/276,703 patent/US20240316201A1/en active Pending
- 2022-02-25 JP JP2023552072A patent/JP2024507958A/ja active Pending
- 2022-02-25 EP EP22758977.7A patent/EP4298210A4/en active Pending
- 2022-02-25 CN CN202280015580.4A patent/CN116964195A/zh active Pending
- 2022-02-25 WO PCT/CN2022/077964 patent/WO2022179613A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022113880A5 (https=) | ||
| JP2025028239A5 (https=) | ||
| JP2021094037A5 (https=) | ||
| JP2020511136A5 (https=) | ||
| JP2025065142A5 (https=) | ||
| JP2020114264A5 (https=) | ||
| JP2021087455A5 (https=) | ||
| JP2018508219A5 (https=) | ||
| JP2020517295A5 (https=) | ||
| HRP20231542T1 (hr) | Kimerni antigenski receptori koji ciljaju bcma i postupci njihove uporabe | |
| JP2021177771A5 (https=) | ||
| JP2021106605A5 (https=) | ||
| JP2022542543A5 (https=) | ||
| CN113227379A (zh) | 多功能多靶向嵌合抗原受体（car）系统及其使用方法 | |
| JP2022534680A5 (https=) | ||
| JP2022543742A5 (https=) | ||
| JP2020525536A5 (https=) | ||
| JP2020513754A5 (https=) | ||
| JP2021532742A5 (https=) | ||
| JP2022545815A5 (https=) | ||
| WO2017176525A1 (en) | Car having replicated binding motifs in a co-stimulatory domain | |
| US11945878B2 (en) | Switch molecule and switchable chimeric antigen receptor | |
| JP2018525006A5 (https=) | ||
| JP2022537159A5 (https=) | ||
| JP2021515598A5 (https=) |